<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-02-28" modified="2017-03-15" version="165">
<accession>Q9Y2W1</accession>
<accession>D3DPS5</accession>
<accession>Q5VTK6</accession>
<name>TR150_HUMAN</name>
<protein>
<recommendedName>
<fullName>Thyroid hormone receptor-associated protein 3</fullName>
</recommendedName>
<alternativeName>
<fullName>Thyroid hormone receptor-associated protein complex 150 kDa component</fullName>
<shortName>Trap150</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">THRAP3</name>
<name type="synonym">TRAP150</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Mol. Cell" volume="3" first="361" last="370">
<title>Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators.</title>
<authorList>
<person name="Ito M."/>
<person name="Yuan C.-X."/>
<person name="Malik S."/>
<person name="Gu W."/>
<person name="Fondell J.D."/>
<person name="Yamamura S."/>
<person name="Fu Z.-Y."/>
<person name="Zhang X."/>
<person name="Qin J."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="10198638"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)80463-3"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>PROTEIN SEQUENCE OF 490-500</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>IDENTIFICATION IN TRAP COMPLEX</scope>
<scope>VARIANT VAL-201</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT VAL-201</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT VAL-201</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Heiserich L."/>
<person name="Boulahbel H."/>
<person name="Gottlieb E."/>
<person name="Lilla S."/>
<person name="von Kriegsheim A."/>
<person name="Lempens A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 186-202; 216-245; 253-261; 314-333; 376-387; 443-451; 468-481; 486-498; 573-591; 609-653; 678-687; 710-718; 792-802; 864-876; 879-893 AND 927-944</scope>
<scope>METHYLATION AT ARG-17</scope>
<scope>PHOSPHORYLATION AT SER-243; SER-320 AND SER-682</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Colon carcinoma</tissue>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
<title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
<authorList>
<person name="Brill L.M."/>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Mukherji M."/>
<person name="Stettler-Gill M."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="15144186"/>
<dbReference type="DOI" id="10.1021/ac035352d"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-243; SER-248; SER-253; SER-315; SER-320; SER-575; SER-672 AND SER-928</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2007" name="RNA" volume="13" first="116" last="128">
<title>Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment.</title>
<authorList>
<person name="Merz C."/>
<person name="Urlaub H."/>
<person name="Will C.L."/>
<person name="Luhrmann R."/>
</authorList>
<dbReference type="PubMed" id="17095540"/>
<dbReference type="DOI" id="10.1261/rna.336807"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="7621" last="7628">
<title>Regulation of cyclin D1 RNA stability by SNIP1.</title>
<authorList>
<person name="Bracken C.P."/>
<person name="Wall S.J."/>
<person name="Barre B."/>
<person name="Panov K.I."/>
<person name="Ajuh P.M."/>
<person name="Perkins N.D."/>
</authorList>
<dbReference type="PubMed" id="18794151"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-08-1217"/>
</citation>
<scope>IDENTIFICATION IN THE SNARP COMPLEX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-248 AND SER-253</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="5167" last="5176">
<title>Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.</title>
<authorList>
<person name="Carrascal M."/>
<person name="Ovelleiro D."/>
<person name="Casas V."/>
<person name="Gay M."/>
<person name="Abian J."/>
</authorList>
<dbReference type="PubMed" id="19367720"/>
<dbReference type="DOI" id="10.1021/pr800500r"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-237; SER-240; SER-243; SER-248; SER-253; SER-379; SER-406; SER-408; SER-575; SER-682; THR-874; SER-928 AND SER-939</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
<title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
<authorList>
<person name="Han G."/>
<person name="Ye M."/>
<person name="Zhou H."/>
<person name="Jiang X."/>
<person name="Feng S."/>
<person name="Jiang X."/>
<person name="Tian R."/>
<person name="Wan D."/>
<person name="Zou H."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="18318008"/>
<dbReference type="DOI" id="10.1002/pmic.200700884"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-928</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-874; SER-928 AND SER-939</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-221; LYS-455; LYS-519 AND LYS-811</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="Mol. Cell" volume="40" first="126" last="137">
<title>Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing.</title>
<authorList>
<person name="Heyd F."/>
<person name="Lynch K.W."/>
</authorList>
<dbReference type="PubMed" id="20932480"/>
<dbReference type="DOI" id="10.1016/j.molcel.2010.09.013"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SFPQ</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="3340" last="3350">
<title>TRAP150 activates pre-mRNA splicing and promotes nuclear mRNA degradation.</title>
<authorList>
<person name="Lee K.M."/>
<person name="Hsu I.W."/>
<person name="Tarn W.Y."/>
</authorList>
<dbReference type="PubMed" id="20123736"/>
<dbReference type="DOI" id="10.1093/nar/gkq017"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH NXF1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-232; SER-243; SER-248; SER-253; SER-257; SER-315; SER-320; SER-379; SER-408; SER-575; SER-622; SER-682; SER-698; SER-928 AND SER-939</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-243; SER-253; SER-315; SER-320; SER-339; SER-379; SER-406; SER-408; SER-535; SER-575; SER-622; SER-682; SER-698; SER-928 AND SER-939</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="Mol. Cell" volume="46" first="212" last="225">
<title>Proteomic investigations reveal a role for RNA processing factor THRAP3 in the DNA damage response.</title>
<authorList>
<person name="Beli P."/>
<person name="Lukashchuk N."/>
<person name="Wagner S.A."/>
<person name="Weinert B.T."/>
<person name="Olsen J.V."/>
<person name="Baskcomb L."/>
<person name="Mann M."/>
<person name="Jackson S.P."/>
<person name="Choudhary C."/>
</authorList>
<dbReference type="PubMed" id="22424773"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.01.026"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF SER-406 AND SER-408</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="33292" last="33302">
<title>Identification of Wilms' tumor 1-associating protein complex and its role in alternative splicing and the cell cycle.</title>
<authorList>
<person name="Horiuchi K."/>
<person name="Kawamura T."/>
<person name="Iwanari H."/>
<person name="Ohashi R."/>
<person name="Naito M."/>
<person name="Kodama T."/>
<person name="Hamakubo T."/>
</authorList>
<dbReference type="PubMed" id="24100041"/>
<dbReference type="DOI" id="10.1074/jbc.M113.500397"/>
</citation>
<scope>IDENTIFICATION IN THE WTAP COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-220; SER-232; SER-237; SER-240; SER-243; SER-248; SER-253; SER-257; SER-315; SER-320; SER-323; SER-326; SER-377; SER-379; THR-397; SER-406; SER-408; SER-444; SER-468; SER-560; SER-562; SER-575; SER-619; SER-682; SER-698; THR-874; SER-928 AND SER-939</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2013" name="Mol. Cell" volume="52" first="272" last="285">
<title>Proteome-wide identification of poly(ADP-Ribosyl)ation targets in different genotoxic stress responses.</title>
<authorList>
<person name="Jungmichel S."/>
<person name="Rosenthal F."/>
<person name="Altmeyer M."/>
<person name="Lukas J."/>
<person name="Hottiger M.O."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="24055347"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.08.026"/>
</citation>
<scope>ADP-RIBOSYLATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="Mol. Endocrinol." volume="27" first="769" last="780">
<title>THRAP3 interacts with HELZ2 and plays a novel role in adipocyte differentiation.</title>
<authorList>
<person name="Katano-Toki A."/>
<person name="Satoh T."/>
<person name="Tomaru T."/>
<person name="Yoshino S."/>
<person name="Ishizuka T."/>
<person name="Ishii S."/>
<person name="Ozawa A."/>
<person name="Shibusawa N."/>
<person name="Tsuchiya T."/>
<person name="Saito T."/>
<person name="Shimizu H."/>
<person name="Hashimoto K."/>
<person name="Okada S."/>
<person name="Yamada M."/>
<person name="Mori M."/>
</authorList>
<dbReference type="PubMed" id="23525231"/>
<dbReference type="DOI" id="10.1210/me.2012-1332"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HELZ2 AND PPARG</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="16021" last="16026">
<title>A positive feedback loop links circadian clock factor CLOCK-BMAL1 to the basic transcriptional machinery.</title>
<authorList>
<person name="Lande-Diner L."/>
<person name="Boyault C."/>
<person name="Kim J.Y."/>
<person name="Weitz C.J."/>
</authorList>
<dbReference type="PubMed" id="24043798"/>
<dbReference type="DOI" id="10.1073/pnas.1305980110"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-248; SER-253; SER-257; SER-320; SER-377; SER-560; SER-575; SER-682 AND SER-684</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-66; ARG-101; ARG-108 AND LYS-252</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-451; LYS-467; LYS-470; LYS-486; LYS-705; LYS-711; LYS-756 AND LYS-759</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-202; LYS-387 AND LYS-451</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-486</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.O114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-396; LYS-427; LYS-451; LYS-470; LYS-486; LYS-527; LYS-697; LYS-705 AND LYS-711</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<comment type="function">
<text evidence="26 27 28 29 30">Involved in pre-mRNA splicing. Remains associated with spliced mRNA after splicing which probably involves interactions with the exon junction complex (EJC). Can trigger mRNA decay which seems to be independent of nonsense-mediated decay involving premature stop codons (PTC) recognition. May be involved in nuclear mRNA decay. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45 is proposed to sequester phosphorylated SFPQ from PTPRC/CD45 pre-mRNA in resting T-cells. Involved in cyclin-D1/CCND1 mRNA stability probably by acting as component of the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in response to DNA damage. Is excluced from DNA damage sites in a manner that parallels transcription inhibition; the function may involve the SNARP complex. Initially thought to play a role in transcriptional coactivation through its association with the TRAP complex; however, it is not regarded as a stable Mediator complex subunit. Cooperatively with HELZ2, enhances the transcriptional activation mediated by PPARG, maybe through the stabilization of the PPARG binding to DNA in presence of ligand. May play a role in the terminal stage of adipocyte differentiation. Plays a role in the positive regulation of the circadian clock. Acts as a coactivator of the CLOCK-ARNTL/BMAL1 heterodimer and promotes its transcriptional activator activity and binding to circadian target genes (PubMed:24043798).</text>
</comment>
<comment type="subunit">
<text evidence="20 22 24 25 26 27 29 31">Associated with the large multiprotein complex TRAP (Mediator complex-like). Interacts with SFPQ; the interaction is dependent on SFPQ phosphorylation at 'Thr-687' and inhibits binding of SFPQ to an ESS1 exonic splicing silencer element-containing RNA. Interacts with NXF1. Component of the SNARP complex which consists at least of SNIP1, SNW1, THRAP3, BCLAF1 and PNN. Associated with spliced mRNP complexes. Interacts with HELZ2 and PPARG. Interacts with CLOCK and ARNTL/BMAL1 (By similarity). Component of the WTAP complex composed of WTAP, ZC3H13, CBLL1, KIAA1429, RBM15, BCLAF1 and THRAP3.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352039"/>
<interactant intactId="EBI-299104">
<id>P38919</id>
<label>EIF4A3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352039"/>
<interactant intactId="EBI-398874">
<id>Q9UBU9</id>
<label>NXF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352039"/>
<interactant intactId="EBI-355453">
<id>P23246</id>
<label>SFPQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352039"/>
<interactant intactId="EBI-632715">
<id>Q13573</id>
<label>SNW1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="26 29">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Nucleus</location>
<location evidence="31">Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Nucleus speckle</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="22">Ubiquitous.</text>
</comment>
<comment type="PTM">
<text>ADP-ribosylation during genotoxic stress promotes accumulation in nuclear speckles.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAH37554" version="1"/>
</conflict>
<text>Contaminating sequence. Potential poly-A sequence.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/THRAP3ID42960ch1p34.html"/>
</comment>
<dbReference type="EMBL" id="AF117756">
<property type="protein sequence ID" value="AAD22034.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591845">
<property type="protein sequence ID" value="CAH71859.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX07379.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX07380.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC037554">
<property type="protein sequence ID" value="AAH37554.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112330">
<property type="protein sequence ID" value="AAI12331.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC112350">
<property type="protein sequence ID" value="AAI12351.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS405.1"/>
<dbReference type="RefSeq" id="NP_001308400.1">
<property type="nucleotide sequence ID" value="NM_001321471.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001308402.1">
<property type="nucleotide sequence ID" value="NM_001321473.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005110.2">
<property type="nucleotide sequence ID" value="NM_005119.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.744057"/>
<dbReference type="ProteinModelPortal" id="Q9Y2W1"/>
<dbReference type="BioGrid" id="115292">
<property type="interactions" value="127"/>
</dbReference>
<dbReference type="IntAct" id="Q9Y2W1">
<property type="interactions" value="47"/>
</dbReference>
<dbReference type="MINT" id="MINT-1684118"/>
<dbReference type="STRING" id="9606.ENSP00000346634"/>
<dbReference type="iPTMnet" id="Q9Y2W1"/>
<dbReference type="PhosphoSitePlus" id="Q9Y2W1"/>
<dbReference type="SwissPalm" id="Q9Y2W1"/>
<dbReference type="BioMuta" id="THRAP3"/>
<dbReference type="DMDM" id="97537467"/>
<dbReference type="EPD" id="Q9Y2W1"/>
<dbReference type="MaxQB" id="Q9Y2W1"/>
<dbReference type="PaxDb" id="Q9Y2W1"/>
<dbReference type="PeptideAtlas" id="Q9Y2W1"/>
<dbReference type="PRIDE" id="Q9Y2W1"/>
<dbReference type="TopDownProteomics" id="Q9Y2W1"/>
<dbReference type="DNASU" id="9967"/>
<dbReference type="Ensembl" id="ENST00000354618">
<property type="protein sequence ID" value="ENSP00000346634"/>
<property type="gene ID" value="ENSG00000054118"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000469141">
<property type="protein sequence ID" value="ENSP00000433825"/>
<property type="gene ID" value="ENSG00000054118"/>
</dbReference>
<dbReference type="GeneID" id="9967"/>
<dbReference type="KEGG" id="hsa:9967"/>
<dbReference type="UCSC" id="uc001cae.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9967"/>
<dbReference type="DisGeNET" id="9967"/>
<dbReference type="GeneCards" id="THRAP3"/>
<dbReference type="HGNC" id="HGNC:22964">
<property type="gene designation" value="THRAP3"/>
</dbReference>
<dbReference type="HPA" id="CAB017472"/>
<dbReference type="HPA" id="HPA012041"/>
<dbReference type="HPA" id="HPA063765"/>
<dbReference type="MIM" id="603809">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y2W1"/>
<dbReference type="OpenTargets" id="ENSG00000054118"/>
<dbReference type="PharmGKB" id="PA134893249"/>
<dbReference type="eggNOG" id="ENOG410IE11">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZR5P">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063211"/>
<dbReference type="HOGENOM" id="HOG000231570"/>
<dbReference type="HOVERGEN" id="HBG054554"/>
<dbReference type="InParanoid" id="Q9Y2W1"/>
<dbReference type="KO" id="K13112"/>
<dbReference type="OMA" id="RSTEKTE"/>
<dbReference type="OrthoDB" id="EOG091G03HU"/>
<dbReference type="PhylomeDB" id="Q9Y2W1"/>
<dbReference type="TreeFam" id="TF335939"/>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="SignaLink" id="Q9Y2W1"/>
<dbReference type="SIGNOR" id="Q9Y2W1"/>
<dbReference type="ChiTaRS" id="THRAP3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="THRAP3"/>
<dbReference type="GenomeRNAi" id="9967"/>
<dbReference type="PRO" id="PR:Q9Y2W1"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000054118"/>
<dbReference type="CleanEx" id="HS_THRAP3"/>
<dbReference type="ExpressionAtlas" id="Q9Y2W1">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y2W1">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016592">
<property type="term" value="C:mediator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001046">
<property type="term" value="F:core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030374">
<property type="term" value="F:ligand-dependent nuclear receptor transcription coactivator activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051219">
<property type="term" value="F:phosphoprotein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004872">
<property type="term" value="F:receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001104">
<property type="term" value="F:RNA polymerase II transcription cofactor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046966">
<property type="term" value="F:thyroid hormone receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003712">
<property type="term" value="F:transcription cofactor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042809">
<property type="term" value="F:vitamin D receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030518">
<property type="term" value="P:intracellular steroid hormone receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006397">
<property type="term" value="P:mRNA processing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048255">
<property type="term" value="P:mRNA stabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000956">
<property type="term" value="P:nuclear-transcribed mRNA catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042753">
<property type="term" value="P:positive regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048026">
<property type="term" value="P:positive regulation of mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000381">
<property type="term" value="P:regulation of alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008380">
<property type="term" value="P:RNA splicing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR026667">
<property type="entry name" value="THRAP3"/>
</dbReference>
<dbReference type="InterPro" id="IPR029199">
<property type="entry name" value="THRAP3_BCLAF1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15268:SF19">
<property type="entry name" value="PTHR15268:SF19"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF15440">
<property type="entry name" value="THRAP3_BCLAF1"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0013">ADP-ribosylation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0508">mRNA splicing</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="12">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Thyroid hormone receptor-associated protein 3" id="PRO_0000065583">
<location>
<begin position="2"/>
<end position="955"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="21">
<location>
<begin position="552"/>
<end position="559"/>
</location>
</feature>
<feature type="region of interest" description="Required for mRNA splicing activation">
<location>
<begin position="2"/>
<end position="190"/>
</location>
</feature>
<feature type="region of interest" description="Required for mRNA decay activity">
<location>
<begin position="359"/>
<end position="955"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="7"/>
<end position="339"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg-rich">
<location>
<begin position="12"/>
<end position="161"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="12">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Dimethylated arginine" evidence="33">
<location>
<position position="17"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="14">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="14">
<location>
<position position="101"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="14">
<location>
<position position="108"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="220"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="221"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10 13">
<location>
<position position="232"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 13">
<location>
<position position="237"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 13">
<location>
<position position="240"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1 2 3 5 6 7 10 11 13 33">
<location>
<position position="243"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 5 10 13 15">
<location>
<position position="248"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine" evidence="14">
<location>
<position position="252"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 5 10 11 13 15">
<location>
<position position="253"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 13 15">
<location>
<position position="257"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 10 11 13">
<location>
<position position="315"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 10 11 13 15 33">
<location>
<position position="320"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="323"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="20">
<location>
<position position="324"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="326"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="20">
<location>
<position position="328"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="339"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="20">
<location>
<position position="346"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 15">
<location>
<position position="377"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10 11 13">
<location>
<position position="379"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="397"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 11 13">
<location>
<position position="406"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10 11 13">
<location>
<position position="408"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="444"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="455"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="468"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="20">
<location>
<position position="470"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="20">
<location>
<position position="481"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="519"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="20">
<location>
<position position="527"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="535"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="20">
<location>
<position position="558"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 15">
<location>
<position position="560"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="562"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 5 10 11 13 15">
<location>
<position position="575"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="619"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11">
<location>
<position position="622"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2">
<location>
<position position="672"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10 11 13 15 33">
<location>
<position position="682"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="684"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 13">
<location>
<position position="698"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="811"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="20">
<location>
<position position="845"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5 9 13">
<location>
<position position="874"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4 5 9 10 11 13">
<location>
<position position="928"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 9 10 11 13">
<location>
<position position="939"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="16">
<location>
<position position="202"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="16">
<location>
<position position="387"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="396"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="427"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="16">
<location>
<position position="451"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16 17 18">
<location>
<position position="451"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="467"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="17 18">
<location>
<position position="470"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17 18 19">
<location>
<position position="486"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="18">
<location>
<position position="527"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18">
<location>
<position position="697"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17 18">
<location>
<position position="705"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17 18">
<location>
<position position="711"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="756"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="17">
<location>
<position position="759"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6425977." id="VAR_024552" evidence="22 23 32">
<original>A</original>
<variation>V</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces phosphorylation upon DNA damage; when associated with A-408." evidence="28">
<original>S</original>
<variation>A</variation>
<location>
<position position="406"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces phosphorylation upon DNA damage; when associated with A-406." evidence="28">
<original>S</original>
<variation>A</variation>
<location>
<position position="408"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18318008"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19367720"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q569Z6"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000255"/>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10198638"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17095540"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18794151"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20123736"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20932480"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22424773"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23525231"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24043798"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24100041"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="33" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<sequence length="955" mass="108666" checksum="01131D2479B8C0F4" modified="2006-05-16" version="2">
MSKTNKSKSGSRSSRSRSASRSRSRSFSKSRSRSRSLSRSRKRRLSSRSRSRSYSPAHNR
ERNHPRVYQNRDFRGHNRGYRRPYYFRGRNRGFYPWGQYNRGGYGNYRSNWQNYRQAYSP
RRGRSRSRSPKRRSPSPRSRSHSRNSDKSSSDRSRRSSSSRSSSNHSRVESSKRKSAKEK
KSSSKDSRPSQAAGDNQGDEAKEQTFSGGTSQDTKASESSKPWPDATYGTGSASRASAVS
ELSPRERSPALKSPLQSVVVRRRSPRPSPVPKPSPPLSSTSQMGSTLPSGAGYQSGTHQG
QFDHGSGSLSPSKKSPVGKSPPSTGSTYGSSQKEESAASGGAAYTKRYLEEQKTENGKDK
EQKQTNTDKEKIKEKGSFSDTGLGDGKMKSDSFAPKTDSEKPFRGSQSPKRYKLRDDFEK
KMADFHKEEMDDQDKDKAKGRKESEFDDEPKFMSKVIGANKNQEEEKSGKWEGLVYAPPG
KEKQRKTEELEEESFPERSKKEDRGKRSEGGHRGFVPEKNFRVTAYKAVQEKSSSPPPRK
TSESRDKLGAKGDFPTGKSSFSITREAQVNVRMDSFDEDLARPSGLLAQERKLCRDLVHS
NKKEQEFRSIFQHIQSAQSQRSPSELFAQHIVTIVHHVKEHHFGSSGMTLHERFTKYLKR
GTEQEAAKNKKSPEIHRRIDISPSTFRKHGLAHDEMKSPREPGYKAEGKYKDDPVDLRLD
IERRKKHKERDLKRGKSRESVDSRDSSHSRERSAEKTEKTHKGSKKQKKHRRARDRSRSS
SSSSQSSHSYKAEEYTEETEEREESTTGFDKSRLGTKDFVGPSERGGGRARGTFQFRARG
RGWGRGNYSGNNNNNSNNDFQKRNREEEWDPEYTPKSKKYYLHDDREGEGSDKWVSRGRG
RGAFPRGRGRFMFRKSSTSPKWAHDKFSGEEGEIEDDESGTENREEKDNIQPTTE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>